Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Open-label, Single Dose, Crossover Study to Compare the Pharmacokinetic Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 (1000/10mg) in Healthy Male Volunteers

Trial Profile

A Randomized, Open-label, Single Dose, Crossover Study to Compare the Pharmacokinetic Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 (1000/10mg) in Healthy Male Volunteers

Recruiting
Phase of Trial: Phase I

Latest Information Update: 24 Nov 2018

At a glance

  • Drugs Metformin/rosuvastatin (Primary) ; Metformin; Rosuvastatin
  • Indications Diabetes mellitus; Hyperlipidaemia
  • Focus Pharmacokinetics
  • Sponsors Jeil Pharmaceutical
  • Most Recent Events

    • 14 Nov 2018 Planned initiation date (estimated date for recruitment of the first subject) changed from 1 Oct 2018 to 1 Dec 2018.
    • 25 Oct 2018 Status changed from not yet recruiting to recruiting.
    • 05 Oct 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top